HomeCompareRELV vs ARCC

RELV vs ARCC: Dividend Comparison 2026

RELV yields 96.57% · ARCC yields 10.82%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RELV wins by $3.36M in total portfolio value
10 years
RELV
RELV
● Live price
96.57%
Share price
$2.07
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.38M
Annual income
$1,113,866.13
Full RELV calculator →
ARCC
Ares Capital Corporation
● Live price
10.82%
Share price
$17.74
Annual div
$1.92
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.5K
Annual income
$1.16
Full ARCC calculator →

Portfolio growth — RELV vs ARCC

📍 RELV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRELVARCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RELV + ARCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RELV pays
ARCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RELV
Annual income on $10K today (after 15% tax)
$8,208.59/yr
After 10yr DRIP, annual income (after tax)
$946,786.21/yr
ARCC
Annual income on $10K today (after 15% tax)
$919.95/yr
After 10yr DRIP, annual income (after tax)
$0.99/yr
At 15% tax rate, RELV beats the other by $946,785.22/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RELV + ARCC for your $10,000?

RELV: 50%ARCC: 50%
100% ARCC50/50100% RELV
Portfolio after 10yr
$1.70M
Annual income
$556,933.64/yr
Blended yield
32.69%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ARCC right now

RELV
No analyst data
Altman Z
0.7
Piotroski
2/9
ARCC
Analyst Ratings
24
Buy
7
Hold
Consensus: Buy
Price Target
$21.88
+23.3% upside vs current
Range: $21.00 — $23.00
Altman Z
0.8
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RELV buys
0
ARCC buys
0
No recent congressional trades found for RELV or ARCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRELVARCC
Forward yield96.57%10.82%
Annual dividend / share$2.00$1.92
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-50%
Portfolio after 10y$3.38M$24.5K
Annual income after 10y$1,113,866.13$1.16
Total dividends collected$3.01M$1.1K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: RELV vs ARCC ($10,000, DRIP)

YearRELV PortfolioRELV Income/yrARCC PortfolioARCC Income/yrGap
1← crossover$20,357$9,657.17$11,381$541.15+$9.0KRELV
2$40,155$18,373.15$12,621$284.08+$27.5KRELV
3$76,837$33,870.80$13,827$145.31+$63.0KRELV
4$142,787$60,571.58$15,062$73.43+$127.7KRELV
5$257,979$105,197.14$16,364$36.89+$241.6KRELV
6$453,668$177,629.88$17,757$18.49+$435.9KRELV
7$777,359$291,934.37$19,258$9.25+$758.1KRELV
8$1,299,278$467,503.71$20,880$4.63+$1.28MRELV
9$2,120,494$730,267.02$22,636$2.32+$2.10MRELV
10$3,382,795$1,113,866.13$24,539$1.16+$3.36MRELV

RELV vs ARCC: Complete Analysis 2026

RELVStock

Reliv' International, Inc. develops and markets nutritional supplements that address basic nutrition, specific wellness needs, weight management, and sports nutrition. The company's basic nutritional supplements are formulated to provide a balanced and complete level of supplementation for the consumer. Its principal products include Reliv Classic, Reliv Now, Innergize!, and FibRestore along with LunaRich X capsules. The company markets and sells its products through a direct selling system of independent distributors in the United States, Australia, Austria, Canada, France, Germany, Indonesia, Ireland, Malaysia, Mexico, the Netherlands, New Zealand, the Philippines, and the United Kingdom. Reliv' International, Inc. was founded in 1988 and is headquartered in Chesterfield, Missouri.

Full RELV Calculator →

ARCCBDC

Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors. The fund will also consider investments in industries such as restaurants, retail, oil and gas, and technology sectors. It focuses on investments in Northeast, Mid-Atlantic, Southeast and Southwest regions from its New York office, the Midwest region, from the Chicago office, and the Western region from the Los Angeles office. The fund typically invests between $20 million and $200 million and a maximum of $400 million in companies with an EBITDA between $10 million and $250 million. It makes debt investments between $10 million and $100 million The fund invests through revolvers, first lien loans, warrants, unitranche structures, second lien loans, mezzanine debt, private high yield, junior capital, subordinated debt, and non-control preferred and common equity. The fund also selectively considers third-party-led senior and subordinated debt financings and opportunistically considers the purchase of stressed and discounted debt positions. The fund prefers to be an agent and/or lead the transactions in which it invests. The fund also seeks board representation in its portfolio companies.

Full ARCC Calculator →
📬

Get this RELV vs ARCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RELV vs SCHDRELV vs JEPIRELV vs ORELV vs KORELV vs MAINRELV vs HTGCRELV vs GBDCRELV vs ORCC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.